期刊文献+

非肌层浸润性膀胱尿路上皮癌复发相关因素分析 被引量:5

Research on Influencing Factors of Recurrence of Non Muscle-Invasive Bladder Urothelial Cancer
下载PDF
导出
摘要 【目的】探讨影响非肌层浸润性膀胱尿路上皮癌复发的相关因素及其处理对策。【方法】回顾性分析我院2003年1月到2008年12月161例非肌层浸润性膀胱尿路上皮癌患者临床随访资料,所有病例行经尿道膀胱肿瘤电切术,据术后复发率分析影响复发相关因素。【结果】161例中,45例术后复发,术后的总复发率为27.95%。肿瘤分级为G2、G3级患者较G1级患者复发率高;肿瘤分期为T1期患者较Ta期患者复发率高;肿瘤多发患者较肿瘤单发患者复发率高;复发肿瘤患者较初发肿瘤患者复发率高(P<0.05)。肿瘤大小、生长部位及术后用不同药物灌注与肿瘤复发无明显相关(P>0.05)。【结论】肿瘤分级、分期、肿瘤多发以及既往复发情况是影响非肌层浸润性膀胱尿路上皮癌复发的重要因素。 【Objective】To study the influencing factors of the non muscle-invasive bladder urothelial cancer and discuss the appropriate treatment.【Methods】Integrity parameter data were collected from 161 patients with non muscle-invasive bladder cancer in our hospital.They were followed up and the analysis of recurrence rate was performed.【Results】Forty-five of these 161 patients had tumor recurrence,the total recurrence rate was 27.95%.Patients whose tumor grade were G2 or G3 compared to those with G1 tumor,patients whose tumor stage was T1 compared to those with stage Ta tumor,patients with multiple tumors compared to those with solitary tumor,patients who had prior recurrence compared to those with primary tumor had greater recurrence rate(P0.05).Tumor size,tumor location and intravesical instillation after operation with different chemotherapy drugs had no significant correlation with tumor recurrence.【Conclusions】Tumor grade,tumor stage,number of tumors and the prior recurrence condition are important influencing factors of the superficial bladder cancer.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2010年第3期406-408,427,共4页 Journal of Sun Yat-Sen University:Medical Sciences
关键词 非肌层浸润性膀胱尿路上皮癌 复发 影响因素 non muscle-invasive bladder cancer recurrence influencing factors
  • 相关文献

参考文献12

  • 1Willem O,Fred W,Sylvester RJ.Diagnostic and prognostic factors in non-muscle-invasive bladder cancer and their influence on treatment and outcomes[J].Eur Urol,2008,7(Suppl 7):516-523.
  • 2Louis R,Andrew C,Atan W,et al.Campbell-Walsh Urology[M].9th ed.USA:Elsevier Inc,2007(9):2447-2467.
  • 3Lokeshwar VB,Habuchi T,Grossman HB,et al.Bladder tumor markers beyond cytology:international consensus panel on bladder tumor markers[J].Urology,2005,66(Suppl 1):35-63.
  • 4Donat SM.Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer:strategy versus reality[J].J Natl Compr Canc Netw,2009,7(1):40-47.
  • 5Kubin A,Meissner P,Wierrani F,et al.Guidelines on TaT1(Non-muscle invasive) bladder cancer[J].Photochem Photobiol Sci,2008,84(6):1560-1563.
  • 6黄后宝,董昌斌,路建磊,姜书传.表浅性膀胱癌预后与癌肿数目、病理分级的关系[J].现代肿瘤医学,2006,14(4):434-435. 被引量:2
  • 7Fernandez-Gomez J,Solsona E,Unda M,et al.Prognostic factors in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin:multivariate analysis of data from four randomized CUETO trials[J].Eur Urol,2008,53(5):992-1001.
  • 8Sylvester RJ,van der Meijden AP,Oosterlinck W,et al.Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables:A combined analysis of 2596 patients from seven EORTC trials[J].Eur Urol,2006,49(3):466-477.
  • 9Orsola A,Trias I,Raventós CX,et al.Initial highgrade T1 urothelial cell carcinoma:feasibility and prognostic significance of lamina propria invasion microstaging(Tla/b/c)in BCG-treated and non-treated patients[J].Eur Urol,2005,48(2):231-238.
  • 10Stein JP,Penson DF,Wu SD,et al.Pathological guidelines for orthotopic urinary diversion in women with bladder cancer:A review of the literature[J].J Urol,2007,178(3):756-760.

二级参考文献8

  • 1Rodriguez FM,Toniolo GC,Bayarri JS,et al.Multivaritc analysis of the prognostic factors of primary superficial bladder cancer[ J ].J Urol,2000,163 (1):73 ~78.
  • 2Thompson DJ,Campbell KW,Kramer HC,et al.Late invasive recurrence despite long term surveillance for superficial bladder cancer[J].J Urol,1993,149:1010 ~1012.
  • 3Sydransky D,Frost F,Von Eschenbach A,et al.Clonal origin of bladder cancer[ J].N Engl J Med,1992,326:737 ~740.
  • 4Chem HD,Becich MI,Persad RA,et al.Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of p53 and retinoblastoma proteins[J].J Urol,1998,156:1846 ~1849.
  • 5Kurth-K H.Intravesical chemotherapy for superficial bladder tumors calegray Ta/T1:Who should be treated and how[ J ].semin Urol Oncol,1996,14:30 ~ 35.
  • 6Honda Ⅳ,Yamada Y,Mitsui K,et al.Clinical study on recurrence in bladder cancer patients undergoing tofal cystectomy statistical analysis of factors related to recurrence[ J ].Hinyokika Kiyo,1999,45(5):317 324.
  • 7Gohji K,Nomi M,Okamoto M,et al.Concervative therapy for stage T1 b,Grade 3 transitional cell carcinoma of the bladder[ J ].Urology,1999,53(2):308 ~313.
  • 8叶定伟,李慧,Peter Murphy,孙颖浩,钱松溪,郑家富,马永江.膀胱癌多发或复发的克隆起源[J].中华泌尿外科杂志,2000,21(5):280-281. 被引量:4

共引文献3

同被引文献34

  • 1赵凯亮,胡云飞.膀胱移行细胞癌预后因素分析[J].临床外科杂志,2009,17(11). 被引量:4
  • 2刘昊,王志华,叶章群,胡志全.浅表性膀胱癌的灌注治疗[J].肿瘤研究与临床,2006,18(12):854-856. 被引量:4
  • 3吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2008:991-1010.
  • 4Millan-Rodriguez F,Chechile-Toniolo C,Salvador-Bayarri J,et al. Multivariate analysis of the prognostic factors of primary superficial- bladder cancer[J]. J Urol,2000,163( 1 ) :73-78.
  • 5Denzinger S,Burger M,Fritsche HM,et aL Prognostic value of histopatho- logical tumour growth patterns at the invasion front of TlG3 urothe- lial carcinoma of the bladder[J]. Seand J Urol Nephrol,2009,43 (4): 282-287.
  • 6Fritsche HM,Burger M,Svatek RS,et al. Characteristics and out- comes of patients with clinical Tl grade 3 urothelial carcinoma treat- ed with radical cystectomy: results from an international cohort [J]. Eur Urol, 2010,57 (2) : 300-309.
  • 7Borden LS Jr,Clark PE,Hall MC. Bladder cancer[J]. Curr Opin Oncol, 2005,17(3) :275-280.
  • 8Divrik RT,Sahin AF,Yildirim U,et al. Impact of routine second transurethral resection on the long-term outcome ofpatients with new- ly diagnosed pTl urothelial carcinoma with respect to recurrence,pro- gression rate,and diseasespecificsurvival: a prospective randomised clinical trial[J]. Eur Urol,2010,58(2) : 185-190.
  • 9Sylvester RJ,Oosterhnck W ,Witjes JA. The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive blad- der cancer: a systematic review of the published results of random- ized clinical trials[J]. Eur Urol, 2008,53 (4) :709-719.
  • 10Sengup S, Bluteml ML. The management of superficial tuansitional cellcarcinoma of the bladder[ J]. Urology ,2006,67 ( 3 ) :48 - 54.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部